ES2108266T3 - Derivados de fenil sustituido cicloalquil hidroxiureas que inhiben la lipoxigenasa. - Google Patents

Derivados de fenil sustituido cicloalquil hidroxiureas que inhiben la lipoxigenasa.

Info

Publication number
ES2108266T3
ES2108266T3 ES93905957T ES93905957T ES2108266T3 ES 2108266 T3 ES2108266 T3 ES 2108266T3 ES 93905957 T ES93905957 T ES 93905957T ES 93905957 T ES93905957 T ES 93905957T ES 2108266 T3 ES2108266 T3 ES 2108266T3
Authority
ES
Spain
Prior art keywords
alkyl
fenoxi
substituted
halosustituted
lipoxigenasa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93905957T
Other languages
English (en)
Inventor
Kazunari Nakao
Akiyoshi Kawai
Rodney W Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2108266T3 publication Critical patent/ES2108266T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/47—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

CIERTOS NUEVOS COMPONENTES CICLOALQUILUREA FENILSUSTITUIDOS QUE TIENEN LA CAPACIDAD PARA INHIBIR LA ENZIMA 5-LIPOXIGENASA Y QUE TIENE LA FORMULA (I); EN DONDE A ES ALQUILENO C1-C4 O ALQUENILENO C2-C6; CADA B ES INDEPENDIENTEMENTE HALOGENO, ALQUILO C1-C4, ALCOXIALQUILO C2-C8 O ALQUILO C1-C4 HALOXISUSTITUIDO; X ES METILENO O ETILENO; M ES HIDROGENO O UN CATION ACEPTABLE FARMACEUTICAMENTE; AR ES FENIL O FENIL MONO-, DI ITUIDO EN DONDE LOS SUSTITUYENTES SON CADA UNO INDEPENDIENTEMENTE SELECCIONADO DE HALOGENO, ALQUILO C1-C4, ALCOXI C1-C4, ALQUILO HALOSUSTITUIDO C1-C4, (ALQUILO C1-C4) FENOXI, (ALCOXI C1-C4) FENOXI, FENOXI HALOSUSTITUIDO, (ALQUILO C1-C4) FENOXI HALOSUSTITUIDO, FENILTIO, (ALQUILO C1C4) FENILTIO, (ALCOXI C1-C4) FENILTIO, FENILTIO HALOSUSTITUIDO Y (ALQUIL C1-C4) FENILTIO HALOSUSTITUIDO; A,B Y AR DEBEN ESTAR UNIDOS A CUALQUIER POSICION POSIBLE EN EL ANILLO; M ES 0 O 1; Y N ES 0,1 O 2. ESOS COMPONENTES SON UTILES EN EL TRATAMIENTO O ALIVIO DE ENFERMEDADES INFLAMATORIAS, CONDICIONES ALERGICAS Y ENFERMEDADES CARDIOVASCULARES EN MAMIFEROS Y COMO EL INGREDIENTE ACTIVO EN LAS COMPOSICIONES FARMACEUTICAS PARA TRATAR TALES CONDICIONES
ES93905957T 1992-04-17 1993-02-18 Derivados de fenil sustituido cicloalquil hidroxiureas que inhiben la lipoxigenasa. Expired - Lifetime ES2108266T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4098150A JPH05294921A (ja) 1992-04-17 1992-04-17 新規なフェニル置換シクロアルキル尿素誘導体および組成物

Publications (1)

Publication Number Publication Date
ES2108266T3 true ES2108266T3 (es) 1997-12-16

Family

ID=14212150

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93905957T Expired - Lifetime ES2108266T3 (es) 1992-04-17 1993-02-18 Derivados de fenil sustituido cicloalquil hidroxiureas que inhiben la lipoxigenasa.

Country Status (10)

Country Link
EP (1) EP0636119B1 (es)
JP (1) JPH05294921A (es)
AT (1) ATE159933T1 (es)
CA (1) CA2133218C (es)
DE (1) DE69315069T2 (es)
DK (1) DK0636119T3 (es)
ES (1) ES2108266T3 (es)
FI (1) FI944848A0 (es)
GR (1) GR3025692T3 (es)
WO (1) WO1993021149A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW448144B (en) * 1993-08-19 2001-08-01 Pfizer Phenoxyphenyl cyclopentenyl hydroxyureas
AU1120795A (en) * 1993-12-22 1995-07-10 Pfizer Inc. Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
US6832204B1 (en) * 1999-12-27 2004-12-14 Ge-Harris Railway Electronics, Llc Train building planning method
AU2005265093A1 (en) 2004-06-18 2006-01-26 Wyeth Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
US7553964B2 (en) * 2005-06-03 2009-06-30 Abbott Laboratories Cyclobutyl amine derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120752A (en) * 1989-12-28 1992-06-09 Abbott Laboratories Cyclopropyl derivative lipoxygenase inhibitors
ES2095325T3 (es) * 1990-07-25 1997-02-16 Abbott Lab Derivados de acetileno con una actividad de inhibicion de la lipoxigenasa.
GB9025514D0 (en) * 1990-11-23 1991-01-09 Wellcome Found Anti-inflammatory compounds
JP3007138B2 (ja) * 1990-11-27 2000-02-07 ファイザー製薬株式会社 新規なヒドロキサム酸とｎ―ヒドロキシ尿素誘導体およびそれらの組成物
US5283361A (en) * 1991-04-23 1994-02-01 Eli Lilly And Company N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors
JP2989951B2 (ja) * 1991-10-25 1999-12-13 ファイザー製薬株式会社 新規なシクロアルキル尿素誘導体および組成物
US5187192A (en) * 1992-03-13 1993-02-16 Abbott Laboratories Cyclobutyl derivatives having lipoxygenase inhibitory activity

Also Published As

Publication number Publication date
JPH05294921A (ja) 1993-11-09
CA2133218C (en) 2002-07-09
EP0636119A1 (en) 1995-02-01
EP0636119B1 (en) 1997-11-05
FI944848L (fi) 1994-10-14
WO1993021149A1 (en) 1993-10-28
FI944848A7 (fi) 1994-10-14
DE69315069D1 (en) 1997-12-11
CA2133218A1 (en) 1993-10-28
DE69315069T2 (de) 1998-02-26
GR3025692T3 (en) 1998-03-31
FI944848A0 (fi) 1994-10-14
DK0636119T3 (da) 1997-12-22
ATE159933T1 (de) 1997-11-15

Similar Documents

Publication Publication Date Title
GT199700095A (es) Derivados 6,5-heterobiciclicos sustituidos.
ES2069410T3 (es) Nuevos derivados del acido hidroxamico y n-hidroxiurea y su uso.
MX9307208A (es) Compuestos de amidino sustituidos, su elaboracion y metodos de tratamiento.
ES2178037T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que los contienen.
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
ES2051772T3 (es) 2-sustituido-e-fusionado-(1,2,4)-triazol(1,5-c)pirimidinas, composiciones farmaceuticas y sus usos.
MX9205309A (es) Nuevos taxanos substituidos con furilo y tienilo y composiciones farmaceuticas que los contienen
FI953748A0 (fi) Yhdisteitä, joilla on sekä voimakas kalsium antagonisti- että antioksidanttiaktiivisuus sekä niiden käyttö solua suojaavina aineina
PA8486001A1 (es) Composiciones de celecoxib
ECSP941156A (es) 3 bencilaminometil piperidinas substituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines
MX9304360A (es) Derivados de rapamicina y composiciones farmaceuticas de los mismos.
ES2119124T3 (es) Bencimidazoles utiles para el tratamiento de trastornos del sistema nervioso.
AR034858A1 (es) Compuestos elevadores de abca-1,composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento
ES2149215T3 (es) Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p.
ES2193391T3 (es) Antagonistas muscarinicos.
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
ES2150489T3 (es) 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas.
ES2153491T3 (es) Derivados de quinazolina.
CL2004000590A1 (es) Compuestos derivados de 1,3,4-oxadiazol-3-ona, 1,3,4-tiadiazol-2-ona y de 1,2,4-triazol-3-ona; composicion farmaceutica que los contiene; procedimiento de preparacion y su uso en la preparacion de un medicamento en los que esta relacionado el virus v
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
GT199800163A (es) Derivados de 9-amino-3-ceto eritromicina.
AR017640A1 (es) Un derivado de carbohidratos, su uso y una composicion farmaceutica que lo comprende
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
ES2095662T3 (es) Derivados de imidazol con actividad antagonista de la angiotensina ii.
ES2059534T3 (es) Nuevos derivados benzopiranos antihipertensivos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 636119

Country of ref document: ES